Immunization Financing Options Resource Kit

The Immunization Financing Options Resource Kit, a series of short, user-friendly briefing sheets that outline options for financing national immunization services, has been prepared by the Financing Task Force for the GAVI Alliance.

Introduction & Overview and Comparison of Financing Options (1595kb)

Financing options presented in color-coded briefing sheets are as follows:

For domestic public financing options: (715kb)

• General revenues (central level)
  
• General revenues (subnational level)

For external financing options: (1776kb)

• Project grants from bilateral or multilateral agencies
  
• Debt relief proceeds through HIPC ll
  
• Sector-wide approach (SWAp)
  
• National budget support
  
• Vaccine Fund

For "mixed" external and domestic financing options: (363kb)

• Development loans

For domestic private financing options: (kb)

• User fees
  
• Cross-subsidies
  
• Health insurance

For financing instruments: (kb)

• National trust funds
  
• Revolving funds (including PAHO and VII)

In addition, supplementary briefing sheets (kb) cover the key concepts of:

• Essential immunization services
  
• Costing of national immunization programs
  
• Economics of vaccine production
  
• Differential pricing
  
• Sources of additional information

Background documents are also available here.

ACKNOWLDEGMENTS

Immunization Financing Options: A Resource for Policymakers has been prepared principally by Ruth Levine (The World Bank), Sarah England (World Health Organization), and Violaine Mitchell (GAVI Financing Task Force) on behalf of the Financing Task Force of the Global Alliance for Vaccines and Immunization (GAVI). This document and the background papers prepared for this report have been generously supported through the contributions of the Children's Vaccine Program at PATH, United States Agency for International Development through its Partnerships for Health Reform (PHR) project, The World Bank, and World Health Organization. The authors are grateful to the numerous individuals who have provided helpful comments and contributions especially Amie Batson, Alan Brooks, Richard Bumgarner, Brenda Candries, Grace Chee, Brandao Co, Laura Cooley, Sarah Glass, Christy Hanson, Keith Feldon, Pirrko Heinonen, Marianne Hooper, Jim Jones, Miloud Kaddar, Daniel Kress, Patience Kuruneri, François Lacapere, Steve Landry, Ann Levin, Xingzhu Liu, Julie Milstien, Osman Mansoor, Germano Mwabu, Prosper Nyandagazi, Aviva Ron, Bryn Sakagawa, Sally Stevenson, Walter Vandersmissen, and Scott Wittet. The judgments made herein do not necessarily reflect the views of the partners of the Global Alliance for Vaccines and Immunization nor The World Bank's Board of Executive Directors or the countries they represent. The many contributors to this document may not endorse every point, and they bear no responsibility for any errors that remain.